Physician profile

Steven D Head

Podiatrist · Hermitage, TN

NPI 1619080470

$1,200.97

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$207.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $753.28 2019-2023 Augment Injectable, Salvation
Grt US Holding, INC. $124.18 2022
Smith+Nephew, INC. $115.53 2019
Organogenesis INC. $70.37 2019-2020
Crossroads Extremity Systems, LLC $42.08 2019
Horizon Therapeutics Plc $40.82 2019
Medtronic, INC. $25.69 2023 Intellis Adaptivestim
Abbvie INC. $14.57 2023
Arteriocyte Medical Systems, INC. $14.45 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven D Head

$1,200.97

in general payments reported 2019-2025

Years
2019-2023
Top company
Stryker Corporation

https://glasscript.com/doctor/254833/steven-d-head

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.